Home - Products - Others - Other Targets - Hypoletin-7-O-β-D-xylopyranoside

Hypoletin-7-O-β-D-xylopyranoside

CAS No. 126771-28-6

Hypoletin-7-O-β-D-xylopyranoside( ——— )

Catalog No. M38510 CAS No. 126771-28-6

Hypoletin-7-O-β-D-xylopyranoside is a natural compound with antioxidant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hypoletin-7-O-β-D-xylopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Hypoletin-7-O-β-D-xylopyranoside is a natural compound with antioxidant activity.
  • Description
    Hypoletin-7-O-β-D-xylopyranoside is a natural compound with antioxidant activity.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    126771-28-6
  • Formula Weight
    434.35
  • Molecular Formula
    C20H18O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Eun Ha Lee, Flavonoids from the leaves of Thuja orientalis inhibit the aldose reductase and the formation of advanced glycation endproducts. Journal of the Korean Society for Applied Biological Chemistry volume 52, pages448–455 (2009).
molnova catalog
related products
  • Metamorphosin A

    Metamorphosin A

  • Platycodigenin

    Platycodigenin isolated from platycodon grandiflorum, has in vitro anti-proliferative activity against the HSC-T6 cell line.

  • Flavanomarein

    Flavanomarein demonstrates potent antioxidative property, including free radical scavenging activity, inhibition of lipid peroxidation, as well as lipid-lowering effects in human HepG2 hepatocellular carcinoma cells treated with free fatty acids (FFAs).